Group 1 - The biotech sector is experiencing increased discussions around specific covered call trades, indicating a focus on investment strategies within this industry [1] - Equity trading has become volatile in February following a strong performance in January, with concerns about AI advancements impacting sectors like SaaS and insurance [2] - The Biotech Forum, led by an experienced market analyst, offers a model portfolio of 12-20 high upside biotech stocks, along with live discussions and weekly updates [2] Group 2 - The analyst has disclosed a long position in shares of DVN and XLE, indicating a personal investment interest in these companies [3] - Seeking Alpha emphasizes that past performance does not guarantee future results, highlighting the inherent uncertainties in investment outcomes [4]

here's the very simple argument. If you look at the sub notion of compute over time um you know this could be like R&D um spending on compute this could be experimental comput it could be training compute what you know whatever um that some particular lab is is using goes like this no surprise if you have another chart of like um you know log time horizon let's say this this uh meter measure from the um this figure that many of you would have seen on Twitter over time it looks like um uh you know let let's ...